Stay in the know.
Andrew Galvin Appointed to RI Bio Board
Renowned Life Sciences Entrepreneur Appointed RI Bio Executive Director
RI Bio Appoints New Board Chair
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and
RI Bio executive director announces retirement
RI Bio’s Carol Malysz is included in PBN’s Leaders & Achievers
McKee Makes Case for $45 Million in Life Sciences Investments in FY24 Budget
SEG 2023 Spring Programming for Entrepreneurs of All Levels
Expanding waiver of intellectual property protections could jeopardize US biotech dominance
The human endeavor of managing health care data
Biotech Industry News